Biostatistics Support

Expertise and regulatory insights set MMS apart.

Expert biostatisticians at MMS hold the trust of leading pharmaceutical and biotechnology Sponsors. Our biostatistics team has an incomparable, industry-educated skill set and end-game experience to provide support in:

• Sample size calculations,
• Randomization schedules,
• Statistical analysis plans (SAP),
• Data interpretation,
• Collaborative solution finding on data/analysis related hurdles, and much more.

When Sponsors engage an MMS biostatistician, they are guaranteed clarity in understanding the statistical rationale and excellent communication with all team members, including programmers, data management, data scientists, medical writers, and clinicians. 

The success of a clinical trial depends on the strength and knowledge of the biostatistics lead. When supporting Sponsors with statistical analyses and protocol development for global health authority responses and/or publication support, the biostatisticians at MMS are experienced, attentive, methodical, and intuitive.

Enhanced Capabilities with Exploristics and KerusCloud

In 2025, MMS expanded its biostatistics and data science expertise through the acquisition of Exploristics, a leading Statistical analytics solutions provider known for innovation in clinical trial design and simulation. This partnership brings the power of KerusCloud, Exploristics’ flagship cloud-based simulation platform, to MMS clients. KerusCloud enables advanced study simulations, allowing researchers to optimize clinical trial designs, reduce risk, and make data-driven decisions with confidence.

With KerusCloud, Sponsors can:

• Simulate alternate study designs, including novel and complex designs to predict outcomes and mitigate risk and/or accelerate timelines and mitigate cost before trials begin
• Integrate real-world data into simulations for more robust study planning
• Streamline the trial design process, saving time and resources

The integration of Exploristics’ expertise further strengthens our ability to provide cutting-edge design expertise and innovative delivery solutions for today’s most complex clinical challenges.

Read the full details in the press announcement here.